These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 17932160)

  • 21. Left ventricular ejection fraction normalization in cardiac resynchronization therapy and risk of ventricular arrhythmias and clinical outcomes: results from the Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy (MADIT-CRT) trial.
    Ruwald MH; Solomon SD; Foster E; Kutyifa V; Ruwald AC; Sherazi S; McNitt S; Jons C; Moss AJ; Zareba W
    Circulation; 2014 Dec; 130(25):2278-86. PubMed ID: 25301831
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A randomized study of cardiac resynchronization therapy defibrillator versus dual-chamber implantable cardioverter-defibrillator in ischemic cardiomyopathy with narrow QRS: the NARROW-CRT study.
    Muto C; Solimene F; Gallo P; Nastasi M; La Rosa C; Calvanese R; Iengo R; Canciello M; Sangiuolo R; Diemberger I; Ciardiello C; Tuccillo B
    Circ Arrhythm Electrophysiol; 2013 Jun; 6(3):538-45. PubMed ID: 23592833
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.
    Wilkoff BL; Cook JR; Epstein AE; Greene HL; Hallstrom AP; Hsia H; Kutalek SP; Sharma A;
    JAMA; 2002 Dec; 288(24):3115-23. PubMed ID: 12495391
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy of Pharmacologic and Cardiac Implantable Electronic Device Therapies in Patients With Heart Failure and Reduced Ejection Fraction: A Systematic Review and Network Meta-Analysis.
    Tseng AS; Kunze KL; Lee JZ; Amin M; Neville MR; Almader-Douglas D; Killu AM; Madhavan M; Cha YM; Asirvatham SJ; Friedman PA; Gersh BJ; Mulpuru SK
    Circ Arrhythm Electrophysiol; 2019 Jun; 12(6):e006951. PubMed ID: 31159582
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Cardiac resynchronisation therapy by biventricular pacing in severe heart failure].
    Faerestrand S
    Tidsskr Nor Laegeforen; 2004 Apr; 124(8):1111-5. PubMed ID: 15114391
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New indications for implantable defibrillator therapy.
    Poole JE;
    Curr Cardiol Rep; 2006 Sep; 8(5):330-5. PubMed ID: 16956447
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Update of implantable cardioverter/defibrillator and cardiac resynchronization therapy in heart failure.
    Rami T; Shih HT
    Curr Opin Cardiol; 2004 May; 19(3):264-9. PubMed ID: 15096960
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. AVID, CASH and CIDS studies. Antiarrhythmics vs Implantable Defibrillator study. Cardiac Arrest Study Hamburg . Canadian Implantable Defibrillator Study.
    Connolly SJ; Hallstrom AP; Cappato R; Schron EB; Kuck KH; Zipes DP; Greene HL; Boczor S; Domanski M; Follmann D; Gent M; Roberts RS
    Eur Heart J; 2000 Dec; 21(24):2071-8. PubMed ID: 11102258
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effectiveness of Implantation of Cardioverter-Defibrillators Therapy in Patients with Non-Ischemic Heart Failure: an Updated Systematic Review and Meta-Analysis.
    Xing Z; Tang L; Chen C; Huang J; Zhu Z; Hu X
    Braz J Cardiovasc Surg; 2017; 32(5):417-422. PubMed ID: 29211223
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Device Therapies Among Patients Receiving Primary Prevention Implantable Cardioverter-Defibrillators in the Cardiovascular Research Network.
    Greenlee RT; Go AS; Peterson PN; Cassidy-Bushrow AE; Gaber C; Garcia-Montilla R; Glenn KA; Gupta N; Gurwitz JH; Hammill SC; Hayes JJ; Kadish A; Magid DJ; McManus DD; Multerer D; Powers JD; Reifler LM; Reynolds K; Schuger C; Sharma PP; Smith DH; Suits M; Sung SH; Varosy PD; Vidaillet HJ; Masoudi FA
    J Am Heart Assoc; 2018 Mar; 7(7):. PubMed ID: 29581222
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Non-pharmacological treatment of heart failure: implantable cardioverter defibrillator (ICD) and cardiac resynchronisation therapy].
    van Gelder IC; Smit MD; Nieuwland W; van Veldhuisen DJ
    Ned Tijdschr Geneeskd; 2006 Oct; 150(41):2238-44. PubMed ID: 17076357
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Role of cardiac resynchronisation in the treatment of cardiac failure].
    Leclercq C; Crocq C; Mabo P; Daubert C
    Arch Mal Coeur Vaiss; 2004 Nov; 97(11):1116-21. PubMed ID: 15609914
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy of Implantable Cardioverter-Defibrillator Therapy in Patients With Nonischemic Cardiomyopathy: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Anantha Narayanan M; Vakil K; Reddy YN; Baskaran J; Deshmukh A; Benditt DG; Adabag S
    JACC Clin Electrophysiol; 2017 Sep; 3(9):962-970. PubMed ID: 29759721
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Determinants of patient survival rate after implantation of a cardioverter-defibrillator without resynchronisation capability.
    Lelakowski J; Piekarz J; Rydlewska A; Majewski J; Senderek T; Ząbek A; Małecka B
    Kardiol Pol; 2012; 70(11):1099-110. PubMed ID: 23180517
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of left ventricular ejection fraction and QRS duration on the survival benefit of implantable cardioverter-defibrillators: meta-analysis of primary prevention trials.
    Katritsis DG; Siontis KC; Bigger JT; Kadish AH; Steinman R; Zareba W; Siontis GC; Bardy GH; Ioannidis JP
    Heart Rhythm; 2013 Feb; 10(2):200-6. PubMed ID: 23107652
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cardiac resynchronization therapy: a meta-analysis of randomized controlled trials.
    Wells G; Parkash R; Healey JS; Talajic M; Arnold JM; Sullivan S; Peterson J; Yetisir E; Theoret-Patrick P; Luce M; Tang AS
    CMAJ; 2011 Mar; 183(4):421-9. PubMed ID: 21282316
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mortality reduction of cardiac resynchronization and implantable cardioverter-defibrillator therapy in heart failure: an updated meta-analysis. Does recent evidence change the standard of care?
    Bertoldi EG; Polanczyk CA; Cunha V; Ziegelmann PK; Beck-da-Silva L; Rohde LE
    J Card Fail; 2011 Oct; 17(10):860-6. PubMed ID: 21962425
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of implantable cardioverter-defibrillators in patients with continuous flow left ventricular assist devices - A meta-analysis.
    Agrawal S; Garg L; Nanda S; Sharma A; Bhatia N; Manda Y; Singh A; Fegley M; Shirani J
    Int J Cardiol; 2016 Nov; 222():379-384. PubMed ID: 27505320
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cardiac resynchronization therapy: a review of CRT-D versus CRT-P.
    Stabile G; Iuliano A; Turco P; Ciardiello C; De Simone A
    Future Cardiol; 2009 Nov; 5(6):567-72. PubMed ID: 19886783
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Extent of and reasons for nonuse of implantable cardioverter defibrillator devices in clinical practice among eligible patients with left ventricular systolic dysfunction.
    LaPointe NM; Al-Khatib SM; Piccini JP; Atwater BD; Honeycutt E; Thomas K; Shah BR; Zimmer LO; Sanders G; Peterson ED
    Circ Cardiovasc Qual Outcomes; 2011 Mar; 4(2):146-51. PubMed ID: 21304098
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.